Carregant...

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials

BACKGROUND: To date, only dexamethasone has been shown to reduce mortality in coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the treatment guidelines for hospitalized COVID-19 patients, but data remain conflicting. STUDY DESIGN AND METHODS: Electronic databases su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lung
Autors principals: Selvaraj, Vijairam, Khan, Mohammad Saud, Bavishi, Chirag, Dapaah-Afriyie, Kwame, Finn, Arkadiy, Lal, Amos, Mylonakis, Eleftherios
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164079/
https://ncbi.nlm.nih.gov/pubmed/34050796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-021-00451-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!